WeMed Medical Debuts World’s First “Eye-Hand-Brain” Interventional Platform in Latin America: Chinese MedTech Shines in Mexico

WeMed Medical made its debut at Expo Med Hospitalar Mexico 2025. At the event, WeMed Medical unveiled its groundbreaking Eye-Hand-Brain coordinated interventional platform, featuring its flagship product-We RobotDSA, the Endovascular Robotic Medical Angiography X-ray System-demonstrating China's rising leadership in high-end interventional robotics technology.

Trinity Coordination: Disrupting Traditional Interventional Challenges

As the world's only company with fully integrated R&D and manufacturing capabilities for both premium DSA and Endovascular Robotic System, WeMed Medical has a deep understanding of clinical demands. Traditional interventional procedures face persistent challenges: prolonged physician exposure to X-ray radiation, reduced precision due to hand tremors, and intense physical and experiential demands during complex operations.

At the core of We RobotDSA is the "Eye-Hand-Brain" intelligent synergy, an innovative framework that combines real-time image guidance, high-precision manipulation, and AI-driven decision support to transform vascular intervention. Key features include:

• Near-Zero Radiation Environment: Physicians operate remotely from radiation zones, eliminating occupational exposure risks.
• Sub-Millimeter Precision: Operational error under 0.05 mm meets ultra-fine procedural requirements.
• 5G Remote Intervention: Overcomes geographical limitations, enabling top-tier specialists to perform procedures in remote regions.
• World's First Intelligent Force Feedback: With a minimum detection threshold of 0.01 N, the system provides real-time feedback on vessel wall resistance, dramatically reducing guidewire misplacement compared to conventional manual techniques.
• WE-Aimage: Offers clinical-grade imaging through advanced multi-source data fusion technology.

Pioneering Latin America: China's Smart-Tech Elevates Global Healthcare

As the second-largest importer of medical devices in Latin America, Mexico posted a medical equipment import volume of USD 9.3 billion in 2024, reflecting an annual growth rate of 8.2%. Benefiting from proximity to the United States and surgical costs approximately one-third of those in the U.S., Mexico's rapidly growing medical tourism sector continues to drive demand for advanced medical technologies. This dual role-as a regional hub and a high-growth market-positions Mexico as a key strategic point in WeMed Medical's global expansion.

WeMed Medical's inaugural appearance at Expo Med Hospitalar Mexico 2025-the region's largest healthcare exhibition-signaled a major step in its international outreach. Alongside 157 global exhibitors, WeMed Medical explored frontiers in five key sectors: medical equipment and technology, consumables and devices, digital health solutions, hospital facility management, and home healthcare. The event attracted strong engagement from healthcare professionals and distributors across Mexico and Latin America.

The We RobotDSA drew considerable attention with its integrated "Eye-Hand-Brain" architecture, redefining interventional workflows through cutting-edge innovation. The system's unveiling generated significant industry interest and earned praise from attending professionals.

"Latin America's growing healthcare demands are closely aligned with the application of innovative technologies,"said Mr. Li Dashan, Director of Overseas Marketing and Sales at WeMed Medical. "Our solutions will significantly enhance the precision, safety, and accessibility of interventional procedures across the region. This debut in Mexico marks a pivotal transition-from manual intervention to the era of robotic precision-where Chinese MedTech innovation sets new benchmarks in global vascular care."

Looking ahead, WeMed Medical will continue driving technological breakthroughs through intelligent, high-precision medical solutions, strengthening global healthcare ecosystems and advancing its mission of innovating for health.